CD48 is a key molecule of immunomodulation affecting prognosis in glioma

CD48 is a key molecule of immunomodulation affecting prognosis in glioma

Cunyi Zou,1,* Chen Zhu,1,* Gefei Guan,1 Qing Guo,1 Tianqi Liu,1 Shuai Shen,1 Zihao Yan,1 Xiaoyan Xu,2 Zhiguo Lin,3 Ling Chen,4 Anhua Wu,1 Wen Cheng11Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning 110001, People’s Republic of China; 2Departmen...

Full description

Bibliographic Details
Main Authors: Zou C, Zhu C, Guan G, Guo Q, Liu T, Shen S, Yan Z, Xu X, Lin Z, Chen L, Wu A, Cheng W
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:OncoTargets and Therapy
Subjects:
CD48
glioma
prognosis
immunomodulation
immunotherapy
Online Access:https://www.dovepress.com/cd48-is-a-key-molecule-of-immunomodulation-affecting-prognosis-in-glio-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/cd48-is-a-key-molecule-of-immunomodulation-affecting-prognosis-in-glio-peer-reviewed-article-OTT

Similar Items